Chongqing Zhifei Biological Products Co., Ltd.

SZSE:300122.SZ

56.53 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 52,679.01838,264.01130,652.41615,190.36610,587.3185,228.3081,342.569445.947712.738800.938780.178764.62628.74737.314604.047590.336492.429
Cost of Revenue 38,742.22925,395.515,621.8019,268.0096,135.8152,364.93288.06235.219141.765310.793308.055338.252250.586269.306188.504214.853207.377
Gross Profit 13,936.78912,868.51215,030.6155,922.3574,451.5032,863.3781,054.507410.728570.973490.144472.123426.368378.154468.008415.543375.483285.052
Gross Profit Ratio 0.2650.3360.490.390.420.5480.7850.9210.8010.6120.6050.5580.6010.6350.6880.6360.579
Reseach & Development Expenses 968.472854.161552.626299.65169.551142.94278.38158.89458.26639.03833.25821.77422.80815.183000
General & Administrative Expenses 110.5994.35392.52167.46256.01737.79427.93526.97416.72529.86837.59229.74427.13813.1642.03431.23214.065
Selling & Marketing Expenses 2,772.6282,235.2371,834.8071,197.5071,095.58765.317317.099203.672239.142210.639148.978148.84129.537115.241105.804108.94383.754
SG&A 3,450.3962,329.591,927.3281,264.9691,151.598803.111345.034230.647255.867240.506186.571178.584156.675128.4147.838140.17597.819
Other Expenses -311.994382.208239.839187.664154.618-20.429-7.5597.01610.2753.2263.35136.51139.0679.0232.8251.002-0.078
Operating Expenses 4,730.8623,565.9592,719.7921,752.2841,475.7671,058.764506.993361.517369.723329.32309.647240.651215.739176.24157.751149.57105.051
Operating Income 9,205.9268,758.3811,999.9733,895.0832,813.5151,712.647512.2428.783220.628172.073149.678219.725191.166293.906257.513221.38185.568
Operating Income Ratio 0.1750.2290.3910.2560.2660.3280.3820.0650.310.2150.1920.2870.3040.3990.4260.3750.377
Total Other Income Expenses Net 136.367-40.372-68.918-41.011-48.137-112.396-42.833-13.47529.43614.424-9.72970.48767.80311.1582.902-3.7735.489
Income Before Tax 9,342.2938,718.00811,931.0553,854.0722,765.3781,692.218504.68135.737230.687175.248152.747256.204230.217302.925260.694222.139185.49
Income Before Tax Ratio 0.1770.2280.3890.2540.2610.3240.3760.080.3240.2190.1960.3350.3660.4110.4320.3760.377
Income Tax Expense 1,272.4251,179.0081,722.506552.745398.939240.85172.4063.21633.28527.24422.39938.2633.83446.13729.10532.08833.481
Net Income 8,069.8687,53910,208.5483,301.3272,366.4391,451.367432.27532.52197.402148.004130.348217.944196.384256.788231.59190.051152.009
Net Income Ratio 0.1530.1970.3330.2170.2240.2780.3220.0730.2770.1850.1670.2850.3120.3480.3830.3220.309
EPS 3.363.144.251.380.990.60.180.0130.0780.0620.0520.0880.080.110.10.0860.068
EPS Diluted 3.363.144.251.380.990.590.180.0130.0780.0620.0520.0880.080.110.10.0860.068
EBITDA 9,544.3119,616.62112,632.0484,246.5013,017.2971,877.982620.516128.878281.362220.476228.843209.059256.429321.316275.403235.841190.453
EBITDA Ratio 0.1810.2510.4120.280.2850.3590.4620.2890.3950.2750.2930.2730.4080.4360.4560.40.387